Learn About The Law
Get help with your legal needs
FindLaw’s Learn About the Law features thousands of informational articles to help you understand your options. And if you’re ready to hire an attorney, find one in your area who can help.
Current as of January 01, 2025 | Updated by Findlaw Staff
(1)(a) On or before July 1, 2024, the executive director shall submit to the general assembly a report analyzing the feasibility of establishing a standing committee to evaluate cannabinoids and cannabis-derived products for the purpose of determining and making recommendations regarding their safety profiles and potential for intoxication. The report must consider and recommend legislative action addressing the following subjects:
(I) The appropriate state agency or agencies to be involved in, and their role in, the evaluation process;
(II) The ability of a standing committee to determine safety profiles of cannabinoids and cannabis-derived products, including the process by which a standing committee would make such a determination;
(III) The ability of a standing committee to determine the potential for intoxication of cannabinoids and cannabis-derived products, including the process by which a standing committee would make such a determination;
(IV) Recommendations as to members of a standing committee and a process to make appointments of members to a standing committee;
(V) Recommendations regarding an operable timeline for implementation of a standing committee; and
(VI) The fiscal effects of and the resources needed to implement and administer a standing committee.
(b) To inform the feasibility report described in subsection (1)(a) of this section, the department may engage experts, including:
(I) The chief medical officer appointed pursuant to section 25-1-105 or the designee of the chief medical officer;
(II) The state toxicologist or the designee of the state toxicologist;
(III) An epidemiologist with expertise in designing and conducting observational studies or clinical trials;
(IV) A clinician familiar with dosage forms and routes of administration of relevant products;
(V) A medical toxicologist; and
(VI) A pharmacologist with expertise in drug development.
(2) As used in this section, “state toxicologist” means the director of the toxicology and environmental epidemiology office, or a successor office, in the department of public health and environment.
(3) This section is repealed, effective July 1, 2025.
Cite this article: FindLaw.com - Colorado Revised Statutes Title 44. Activities Regulated by the Department of Revenue § 44-10-208. Feasibility report--standing committee--definition--repeal - last updated January 01, 2025 | https://codes.findlaw.com/co/title-44-activities-regulated-by-the-department-of-revenue/co-rev-st-sect-44-10-208/
FindLaw Codes may not reflect the most recent version of the law in your jurisdiction. Please verify the status of the code you are researching with the state legislature before relying on it for your legal needs.
A free source of state and federal court opinions, state laws, and the United States Code. For more information about the legal concepts addressed by these cases and statutes, visit FindLaw’s Learn About the Law.
Get help with your legal needs
FindLaw’s Learn About the Law features thousands of informational articles to help you understand your options. And if you’re ready to hire an attorney, find one in your area who can help.
Search our directory by legal issue
Enter information in one or both fields (Required)